Burgess Michael F. 4
4 · SpringWorks Therapeutics, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Burgess Michael F.
Head of Research & Development
Transactions
- Award
Common Stock
2022-06-30+12,185→ 52,687 total - Tax Payment
Common Stock
2022-06-01$19.61/sh−2,672$52,398→ 40,502 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock awards and does not represent a sale by the Reporting Person.
- [F2]Represents restricted stock awards, which became fully vested on June 30, 2022.